VUTRISIRAN (vue TRI sir AN) treats nerve pain, tingling, or numbness in the hands or feet in people with transthyretin amyloidosis (ATTR). It may also be used to lower the risk of worsening disease and death caused by cardiomyopathy. It works by decreasing the buildup of a protein that causes nerve injury and thickening of the heart muscle. This decreases symptoms. It also makes it easier for your heart to pump blood to the rest of your body.

There is no lifestyle interaction information available for this medication.